Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

CytRx Corporation (CYTR)

-NasdaqCM
3.39 Down 0.08(2.31%) 4:00PM EDT
Prev Close:3.47
Open:3.45
Bid:3.39 x 20000
Ask:3.40 x 6300
1y Target Est:11.00
Beta:1.37
Next Earnings Date:N/A
Day's Range:3.35 - 3.45
52wk Range:2.00 - 8.35
Volume:666,255
Avg Vol (3m):1,638,450
Market Cap:189.08M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 2.31%189.08M
LLYDown 0.92%68.42B
NVSDown 0.81%214.50B
SNYDown 2.04%134.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):645.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.56
Quarterly EPS Est (Jun-14) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback